ANTARA CAPITAL LP – Revance Therapeutics, Inc. Transaction History
ANTARA CAPITAL LP portfolio value:
$109.87M
portfolio value
Revance Therapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | call | Increase | +699.02% | 3.56M shares | 102.83M | $27 | 4.06M |
Q3 2022 | put | Increase | +220.00% | 1.1M shares | 36.29M | $27 | 1.6M |
Q2 2022 | put | Increase | 0.00% | 500K shares | 6.91M | $13.82 | 500K |
Q2 2022 | call | Decrease | -25.06% | -170.3K shares | -6.21M | $13.82 | 509.3K |
Q1 2022 | call | Increase | +239.80% | 479.6K shares | 9.98M | $19.5 | 679.6K |
Q1 2022 | put | Decrease | -100.00% | -250K shares | -4.08M | $19.5 | 0 |
Q1 2022 | share | Decrease | -100.00% | -100K shares | -1.63M | $19.5 | 0 |
Q4 2021 | put | Increase | 0.00% | 250K shares | 4.08M | $16.49 | 250K |
Q4 2021 | call | Increase | 0.00% | 200K shares | 3.26M | $16.49 | 200K |
Q4 2021 | share | Increase | 0.00% | 100K shares | 1.63M | $16.49 | 100K |